[1] Zane C, Leali C, Airo P, et al. "Highdose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol,2001, 44:629-633.
[2] Tzaneva S, Seeber A, Schwaiger M, et al.High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol, 2001, 45:503-507.
[3] Abeek D, Sehmidt T, Fesq H, et al. Longterm efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol, 2000, 42:254-257.
[4] Krutmann J, Diepgen TL, Luger TA, et al.High-dose UVA1 therapy for atopic dermatitis:results of a multicenter trial. J Am Acad Dermatol, 1998, 38:589-593.
[5] yon Kobyletzki G, Pieck C, Hoffmann K, et al. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopie dermatitis. J Am Acad Dermatol, 1999, 41:931-937.
[6] Krutmann J, Czech W, Diepgen T, et al.High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol, 1992, 26:225-230.
[7] Kowalzick L. UVA1 for atopic dermatitis:medium dose superior to low dose. J Am Acad Dermatol, 2001, 44:548.
[8] De Rie MA, Bos JD. Photochemotherapy for systemic and localized scleroderma. J Am Aead Dermatol, 2000, 43:725-726.
[9] Tzaneva S, Seeber A, Schwaiger M, et al.High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol, 2001, 45:503-507.
[10] Stege H, Berneburg M, Humke S, et al.High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol,1997, 36:938-944.
[11] Kerscher M, Volkenandt M, Gruss C, et al.Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol, 1998, 38:21-26.
[12] Gruss C, Reed JA, Altmeyer P, et al. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fi-broblasts. Lancet, 1997, 350:1295-1296.
[13] Morita A, Kobayashi K, Isomura I, et al.Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol, 2000, 43:670-674.
[14] Plettenberg H, Stege H, Megahed M, et al.Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol, 1999, 41:47-50.
[15] von Kobyletzki G, Dirschka T, Freitag M,et al. Ultraviolet-Al phototherapy improves the status of the skin in cutaneous T-cell lymphoma. Br J Dermatol, 1999,140:768-769.
[16] Asawanonda P, Khoo LS, Fitzpatrick TB,et al. UV-A1 for keloid. Arch Dermatol.1999,135:348-349.
[17] Hannuksela-Svahn A, Grandal OJ, ThorsUtensen T, et al. UVA1 for treatmentof keloids. Acta Derm Venereol, 1999, 79:490.
[18] Kreuter JA, Gambichler T, Jansen T, et al.UVA1 cold-light phototherapy of small plaque parapsoriasis. Acta Derm Venereol,2000, 80:390-391.
[19] Kobyletzki GV, Kreuter JA, Nordmeier R,et al. Treatment of idiopathic mucinosis follicularis with UVA1 cold-light phtotherapy. Dermatology, 2000, 20:76-77.
[20] Stege H, Schopf E, Ruzicka T, et al. Highose UVA1 for urticaria pigmentosa.Lancet, 1996, 347:64.
[21] Grundmann-Kollmann M, Behrens S, Gruss C, et al. Chronic sclerodermic graft-versushost disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol, 2000, 42:134-136. |
